| mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
0.008 |
0.8 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
| mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.0086 |
0.8 |
| mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.012 |
0.8 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0074 |
0.9 |
| mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0069 |
0.9 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.0074 |
0.9 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0072 |
0.9 |
| mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
0.0081 |
0.9 |
| mRNA |
bendamustine |
CTRPv2 |
pan-cancer |
AAC |
0.0077 |
0.9 |